Press releases
- Masimo Provides Facts, Exposes False Narratives in Response to Latest Politan Fictions
- Masimo Nominee Christopher Chavez Would Bring Fierce Independence, Exemplary Medtech CEO Experience to Masimo Board
- Masimo Announces Sleep Halo™, Advanced Sleep Analysis for the Masimo W1®
- Masimo and Cleveland Clinic Collaborate to Improve Hospital Remote Care
- Masimo Files Investor Presentation Highlighting Innovation-Driven Value, Strategic Initiatives to Deliver Robust Growth and Margin Expansion and Risks of Ceding Control to Politan
- Politan Details Why a Truly Independent Board is Urgently Needed at Masimo in Order to Protect Shareholder Value and Realize the Company’s Full Potential
- Masimo Board of Directors Files Definitive Proxy and Issues Letter to Stockholders
- Masimo to Present in Goldman Sachs 45th Annual Global Healthcare Conference
- Masimo Joins Forces with the Mobilize Recovery 2024 Bus Tour
- Politan Files Preliminary Proxy Statement
More ▼
Key statistics
On Friday, Masimo Corp (0JZ2:LSE) closed at 114.63, 52.13% above the 52 week low of 75.35 set on Oct 17, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 114.63 |
Low | 114.63 |
Bid | -- |
Offer | -- |
Previous close | 114.63 |
Average volume | 439.44 |
---|---|
Shares outstanding | 53.18m |
Free float | 49.05m |
P/E (TTM) | 78.38 |
Market cap | 6.10bn USD |
EPS (TTM) | 1.46 USD |
Data delayed at least 15 minutes, as of Jul 05 2024 14:52 BST.
More ▼